Home › Trial NCT00126659
Sorafenib in Treating Patients Who Are Undergoing Surgery for Metastatic Kidney Cancer
- Trial IDNCT00126659
- StatusTerminated
- PhasePhase 2
- Study typeInterventional
- SponsorNational Cancer Institute (NCI)
- Enrollment10
- Start date2006-01
- ConditionsClear Cell Renal Cell Carcinoma · Recurrent Renal Cell Cancer · Stage IV Renal Cell Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.